Titlebook: Regulatory and Economic Aspects in Oncology; Evelyn Walter Book 2019 Springer Nature Switzerland AG 2019 Cancer.Targeted Therapy.Monoclona

Gratuitous

mighty

Introduction and Overview,developments in oncology. The traditional approaches of health economics, like health economic evaluation, health technology assessment (HTA), modeling methods, assessing value, pricing techniques, are bound to be altered in the contributions to this book. It is understandable that with the life-thr

揭穿真相

Cost of Cancer: Healthcare Expenditures and Economic Impact, has also not changed very much over the last decades. Cost for cancer drugs has increased as a share of total expenditures, but this has been offset by a reduction of inpatient hospital care for cancer. Accounting for the cost of cancer should not be limited to healthcare expenditures. Resources ar

衣服

Oncology from an HTA and Health Economic Perspective, introduction on the need for economic evaluation in health care and focus on cost-effectiveness and comparative aspects of the evaluation of oncology products, which are of paramount interest to HTA decision-making bodies using economic evaluation in their decision-making framework. As the burden o

詼諧

樣式

Patient-Reported Outcomes in Oncology, Beyond Randomized Controlled Trials,g a human being as a whole. The treatments should deliver benefits that patients can personally perceive. However, the patient’s perspective does not always match the one of those surrounding them. Illustratively, patients’ symptom assessments are more predictable for daily health status, whereas cl

弄臟

乏味

freight